Results 71 to 80 of about 49,424 (197)

THE RISK OF BREAST DISEASE IN RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORIN A

Turkish Journal of Nephrology, 2019
The risk of breast lesion development in patients under immunosupressive therapy is controversial. The aim of this study was to assess the risk of breast disease in female renal transplant recipients Twenty-two female renal transplant recipients with a
İbrahim BERBER, Çağatay AYDIN, Bülent YİĞİT, İzzet TİTİZ, Gülüm ALTACA   +4 more
doaj  

Experimenteller Nachweis der metallbezogenen Funktion eines Cyanobactins

Angewandte Chemie, Volume 138, Issue 25, 15 June 2026.
Patellamide (Cyanobactine) werden von einer cyanobakteriellen Spezies in grosser Menge hergestellt. Diese zyklischen Peptide wurden in der Vergangenheit fast ausschliesslich auf ihre cytotoxischen Eigenschaften untersucht. Wir diskutieren neue experimentelle Daten, die auf eine Metallionen‐abhängige biologische Funktion der Patellamide schliessen ...
Philipp Baur, Timothy A. Hill, Kai‐Chen Wu, Junxian Lim, Brett M. Paterson, Gunasekaran Velmurugan, Bernard M. Degnan, David P. Fairlie, Peter Comba   +8 more
wiley   +1 more source

What Is Your Diagnosis? Cutaneous Mass in a Dog

Veterinary Clinical Pathology, EarlyView.
Ester Quilez, Shannon L. Donahoe
wiley   +1 more source

Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Ferroptosis, an iron‐dependent form of regulated cell death, is a major cell death mode in myocardial ischemia reperfusion (I/R) injury, along with mitochondrial permeability transition‐driven necrosis, which is inhibited by cyclosporine A ...
Kosei Ishimaru, Masataka Ikeda, Hiroko Deguchi Miyamoto, Shun Furusawa, Ko Abe, Masatsugu Watanabe, Takuya Kanamura, Satoshi Fujita, Ryohei Nishimura, Takayuki Toyohara, Shouji Matsushima, Tomoko Koumura, Ken‐ichi Yamada, Hirotaka Imai, Hiroyuki Tsutsui, Tomomi Ide   +15 more
doaj   +1 more source

Sustained Remission in a Case of Lupus Nephritis with Cyclosporin Therapy

Saudi Journal of Kidney Diseases and Transplantation, 2001
Systemic lupus erythematosus (SLE) in severe form still presents a major therapeutic challenge. Aggressive treatment of severe renal lesions has improved the prognosis of renal disease over the last decade.
Rabbani Malik, Shah Syed, Ahmad Aasim
doaj  

Enhanced PIEZO1 expression in mast cells of mastocytosis skin lesions: Relevance to Darier's sign

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page e598-e601, July 2026.
Yoshiaki Kobayashi, Nobuhiro Nakano, Nguyen Quoc Vuong Tran, Yuki Nakamura, Lisa Minai, Takashi Okamoto, Daiki Nakagomi, Tatsuki R. Kataoka, Tatsuyoshi Kawamura, Atsuhito Nakao   +9 more
wiley   +1 more source

Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1

Open Medicine, 2023
Sun Huaibin, Peng Zhiguo, Liu Kao, Liu Shengli   +3 more
doaj   +1 more source

RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis

Biomolecules
Melanoma cells remain resistant to chemotherapy with cisplatin (CisPt) and doxorubicin (DOX). The abnormal expression of Receptor-Interacting Protein Kinase 4 (RIPK4) in certain melanomas contributes to tumour growth through the NFκB and Wnt/β-catenin ...
Bartlomiej Olajossy, Norbert Wronski, Ewelina Madej, Joanna Komperda, Małgorzata Szczygieł, Agnieszka Wolnicka-Glubisz   +5 more
doaj   +1 more source

Cyclosporin-induced remission in an infant with alkylating agents-resistant nephrotic syndrome. A case report

The Turkish Journal of Pediatrics, 1995
The efficacy of cyclosporin-A, a potent immunosuppressive agent, has not been clearly proven in the management of childhood nephrotic syndrome. The occurrence of early relapse as the dose of cyclosporin is tapered or as soon as the drug is stopped
G G Yilmaz, A G Güven
doaj  

A Study of arbutin protective effect on cyclosporin A-induced oxidative damage

Caspian Journal of Internal Medicine, 2015
Background: Cyclosporine A (CsA) is a potent immunosuppressant drug with therapeutic and toxic actions. The use of CsA is limited by its toxicity. Several researchers had proposed that oxidative stress could play an important role in CsA-induced toxicity.
Fatemeh Khadir, Mahdi Pouramir, Gholamali Joorsaraie, Farideh Feizi, Hadi Sorkhi, Fatemeh Yousefi   +5 more
doaj